TIAA CREF Investment Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	$1.56M	Sell	67,142 -2,914	-4%	-$67.7K	﹤0.01%	2121
2018 Q4	$1.45M	Sell	70,056 -2,645	-4%	-$54.6K	﹤0.01%	2135
2018 Q3	$1.58M	Buy	72,701 +36,599	+101%	+$796K	﹤0.01%	2238
2018 Q2	$551K	Buy	36,102 +10,548	+41%	+$161K	﹤0.01%	2747
2018 Q1	$503K	Buy	+25,554	New	+$503K	﹤0.01%	2732